Understanding the effects of Dasatinib, a selective tyrosine kinase receptor inhibitor, in the context of HT29 Colorectal Cancer Cells

Understanding the effects of Dasatinib, a selective tyrosine kinase receptor inhibitor, in the context of HT29 Colorectal Cancer Cells